Cargando…
Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer
Gastric cancers express enhanced levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). Single-nucleotide polymorphisms (SNPs) in MMP and TIMP genes may be associated with disease susceptibility and might also affect their antigen expression. We studied the genotype distribu...
Autores principales: | Kubben, F J G M, Sier, C F M, Meijer, M J W, van den Berg, M, van der Reijden, J J, Griffioen, G, van de Velde, C J H, Lamers, C B H W, Verspaget, H W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360506/ https://www.ncbi.nlm.nih.gov/pubmed/16940985 http://dx.doi.org/10.1038/sj.bjc.6603307 |
Ejemplares similares
-
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer
por: Kubben, F J G M, et al.
Publicado: (2006) -
Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients
por: Hawinkels, L J A C, et al.
Publicado: (2007) -
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
por: Sier, C. F., et al.
Publicado: (1996) -
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not
por: Langers, A M J, et al.
Publicado: (2008) -
MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients
por: Langers, A M J, et al.
Publicado: (2012)